IND-SWIFT LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Ind-Swift Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
9.84₹ 9.95
As on Jan 16, 2026, 4:01 PM IST
Ind-Swift Laboratories Price Performance
Today's LowToday's High
₹99.00₹112.00
₹111.10
52 Weeks' Low52 Weeks' High
₹67.15₹124.45
₹111.10
Open Price
₹101.15
Prev. Close
₹101.15
Volume
44,258
Over the last 5 years, the share price of Ind-Swift Laboratories has gained 8.23% CAGR. Over the past year, the corresponding return has been 6.57%.
Ind-Swift Laboratories’s current P/E of 3.79x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Ind-Swift Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Ind-Swift Laboratories | 21.90 | 14.05 | 6.14 | 3.69 | 6.57 | 19.05 | 8.23 |
| Sun Pharmaceutical Industries | -5.24 | -7.12 | 0.92 | -3.39 | -4.99 | 17.25 | 22.54 |
| Divi's Laboratories | -5.49 | -1.78 | -5.14 | -8.17 | 6.06 | 23.21 | 11.34 |
| Torrent Pharmaceuticals | -0.16 | 6.29 | 13.77 | 16.84 | 25.03 | 36.80 | 24.26 |
| Cipla | -4.29 | -7.25 | -10.27 | -6.23 | -3.38 | 9.66 | 11.16 |
| Lupin | -0.74 | 4.02 | 12.03 | 11.42 | 2.16 | 42.16 | 14.74 |
| Dr. Reddy's Laboratories | -2.34 | -7.90 | -4.32 | -6.49 | -11.94 | 10.87 | 2.52 |
| Mankind Pharma | -3.68 | 1.43 | -11.13 | -18.05 | -16.25 | 15.14 | 8.83 |
| Zydus Lifesciences | -4.39 | -5.80 | -11.20 | -10.27 | -11.88 | 25.50 | 12.20 |
| Alkem Laboratories | 0.75 | 3.98 | 4.79 | 18.38 | 12.29 | 24.33 | 13.48 |
| Aurobindo Pharma | -3.29 | -1.55 | 5.22 | 1.31 | 1.72 | 37.78 | 4.51 |
| Abbott India | -1.97 | -0.43 | -6.73 | -19.08 | 0.04 | 8.01 | 13.12 |
| Laurus Labs | -2.23 | 7.17 | 22.93 | 30.14 | 93.28 | 44.84 | 23.83 |
| Biocon | -0.26 | -3.48 | 5.84 | -3.40 | -1.43 | 14.59 | -3.77 |
| Glenmark Pharmaceuticals | -3.74 | 0.77 | 5.68 | -10.16 | 35.45 | 68.26 | 31.32 |
| GlaxoSmithKline Pharmaceuticals | -2.14 | -8.84 | -14.22 | -26.64 | 14.88 | 21.70 | 9.14 |
| Ipca Laboratories | -2.08 | 4.81 | 16.07 | 2.76 | -3.49 | 20.31 | 7.43 |
| Anthem Biosciences | -4.54 | -11.92 | -20.64 | -15.72 | -15.72 | -5.54 | -3.36 |
| Ajanta Pharma | -5.42 | 1.59 | 11.29 | -0.72 | -6.90 | 31.63 | 18.15 |
| Emcure Pharmaceuticals | 2.63 | 11.84 | 14.79 | 14.78 | 14.60 | 4.75 | 2.83 |
Over the last one year, Ind-Swift Laboratories has gained 6.57% compared to peers like Sun Pharmaceutical Industries (-4.99%), Divi's Laboratories (6.06%), Torrent Pharmaceuticals (25.03%). From a 5 year perspective, Ind-Swift Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (22.54%) and Divi's Laboratories (11.34%).
Ind-Swift Laboratories Financials
Ind-Swift Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 95.24 | 96.92 |
| 10 | 93.15 | 94.62 |
| 20 | 92.5 | 93.72 |
| 50 | 95.47 | 95.32 |
| 100 | 99.03 | 97.29 |
| 200 | 96.47 | 99.18 |
Ind-Swift Laboratories Share Holding Pattern
In the latest quarter, Ind-Swift Laboratories saw a drop in promoter holding to 39.49%, while DII stake unchanged at 0.68%, FII holding fell to 14.80%, and public shareholding moved up to 45.02% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Ind-Swift Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 15, 2026, 12:08 AM IST | Ind-Swift Laboratori - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Jan 06, 2026, 10:13 PM IST | Ind-Swift Laboratori - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 18, 2025, 6:36 PM IST | Ind-Swift Laboratori - Disclosure Under Regulation 10(6)- Report To Stock Exchanges In Respect Of Acquisition Made In Relianc |
| Dec 15, 2025, 11:47 PM IST | Ind-Swift Laboratori - Receipt Of Good Manufacturing Practice (GMP) Certificate From National Center For Public Health And Ph |
| Dec 09, 2025, 12:00 AM IST | Ind-Swift Laboratori - Announcement under Regulation 30 (LODR)-Change in Management |
About Ind-Swift Laboratories
Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 549.65 Cr. and Equity Capital is Rs. 68.74 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressSCO 850, Shivalik Enclave, Chandigarh Chandigarh 160101
- Contact
Management
- Mr. Navrattan MunjalChairman & Managing Director
- Mr. Himanshu JainJoint Managing Director
- Mr. Rishav MehtaExecutive Director
- Mr. Sahil MunjalExecutive Director
- Mr. Rajinder Kumar GuptaIndependent Director
- Mr. Prabhat KhuranaIndependent Director
- Mr. Subodh GuptaIndependent Director
- Ms. Neerja ChathleyIndependent Woman Director
FAQs on Ind-Swift Laboratories Share Price
What is the share price of Ind-Swift Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ind-Swift Laboratories is ₹111.10 as on Jan 16, 2026.
What kind of stock is Ind-Swift Laboratories?
The Ind-Swift Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Ind-Swift Laboratories?
The market cap of Ind-Swift Laboratories is ₹906.70 Cr as on Jan 16, 2026.
What are today's High and Low prices of Ind-Swift Laboratories?
Today’s highest and lowest price of Ind-Swift Laboratories are ₹112.00 and ₹99.00.
What are the 52 Week High and 52 Week Low of Ind-Swift Laboratories?
The 52-week high/low is the highest and lowest price at which Ind-Swift Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Ind-Swift Laboratories is ₹124.45 and 52-week low of Ind-Swift Laboratories is ₹67.15 as on Jan 16, 2026.
How has the Ind-Swift Laboratories performed historically in terms of returns?
The Ind-Swift Laboratories has shown returns of 9.84% over the past day, 14.05% for the past month, 6.14% over 3 months, 6.57% over 1 year, 19.05% across 3 years, and 8.23% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Ind-Swift Laboratories?
P/E ratio of and PB ratio of Ind-Swift Laboratories are 3.79 and 0.69 on Jan 16, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse